← FDA Drug Approvals (Drugs@FDA)

LOTEPREDNOL ETABONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SENTISS · Approved 2021-02-10

Drug application

FDA Application #

ANDA212080

Application type

Abbreviated New Drug Application (Generic)

Brand name

LOTEPREDNOL ETABONATE

Generic name

LOTEPREDNOL ETABONATE

Active ingredients

LOTEPREDNOL ETABONATE

Dosage form

GEL

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

SENTISS

Manufacturer

ARMAS PHARMACEUTICALS INC.

First approval

2021-02-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown